Stock UniverseDerived research view · source repositories remain read-only

Telix Pharmaceuticals Limited (TLX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
38.32
Global Rank
646
Market Cap
2.41B
Latest Close
9.30
RS Composite
-1.18% · G#1450

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-16.29%
3M
23.67%
6M
-3.73%
1Y
-46.80%
3Y
-38.61%
5Y
-38.61%
10Y
-38.61%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 245.63K · 30-day average: 144.35K · Max drawdown over stored range: -69.37%

Research Snapshot

Relative Strength vs SPX

RS Composite-1.18%
20D RS-13.39%
60D RS11.49%
120D RS-7.74%
Global RS Rank1450 · 56.78% percentile
Qualified+ RS Rank521 · 58.59% percentile
Group ScopeQualified+
Primary RS Rank137 · 70.09% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank88 / 701
Primary Percentile87.59
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for TLX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2021FY 2022FY 2023FY 2024FY 2025
Revenue5.5232108.8126332.978516.551803.794
Revenue Growth (YoY)37.332%1870.116%206.01%55.131%55.608%
Gross Profit3.670564.5185203.282319.493381.845
Operating Income-59.0758-50.367734.97955.88319.287
Free Cash Flow-44.1118-48.26217.96618.373-42.985
Free Cash Flow Per Share-0.156-0.1550.0250.053-0.127
EPS (Diluted) GAAP-0.207437-0.2277180.0130.0976-0.0211
EPS Growth6400%6400%6400%650.769%6400%
EPS Non-GAAP
Gross Margin66.456%59.293%61.05%61.851%47.505%
Operating Margin-1069.602%-46.288%10.505%10.818%2.399%
Profit Margin-1059.9%-65.01%1.264%6.521%-0.886%
Free Cash Flow Margin-798.67%-44.353%2.392%3.557%-5.348%
Shares Outstanding (Diluted)282.2056310.6442323.71345.188337.88
Shares Change (YoY)9.692%10.077%4.206%6.635%-2.117%

SEC Quarterly Fundamentals

No processed quarterly rows for TLX.